Company profile for Tetra Pharm Technologies

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Tetra Pharm is committed to investigate new drug candidates, design and develop new drug formulations, conduct clinical trials, and commercialise medicines targeting the endocannabinoid system. With a location in Medicon Valley, one of the leading life-science clusters in Europe, Tetra Pharm is privileged to be part of an environment that occupies some of the best scientists within biotechnology and pharmaceutical manufacturi...
Tetra Pharm is committed to investigate new drug candidates, design and develop new drug formulations, conduct clinical trials, and commercialise medicines targeting the endocannabinoid system. With a location in Medicon Valley, one of the leading life-science clusters in Europe, Tetra Pharm is privileged to be part of an environment that occupies some of the best scientists within biotechnology and pharmaceutical manufacturing in the World.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Denmark
Address
Address
Søndre Jernbanevej 11 3400 Hillerød
Telephone
Telephone
+45 5197 6225
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20241114198426/en

BUSINESSWIRE
14 Nov 2024

https://www.prnewswire.com/news-releases/tetra-pharm-technologies-relocates-to-copenhagen-towers-302249209.html

PR NEWSWIRE
18 Sep 2024

https://www.prnewswire.com/news-releases/tetra-pharm-technologies-and-kvantify-announce-partnership-to-accelerate-the-discovery-of-novel-drug-candidates-targeting-the-endocannabinoid-system-302155982.html

PR NEWSWIRE
30 May 2024

https://www.prnewswire.com/news-releases/tetra-pharm-technologies-and-glysious-announce-collaboration-to-develop-transdermal-combination-drugs-targeting-the-endocannabinoid-system-302123131.html

PR NEWSWIRE
24 Apr 2024

https://www.prnewswire.com/news-releases/tetra-pharm-technologies-introduces-pain-relieving-drug-in-the-united-kingdom-302090301.html

PR NEWSWIRE
19 Mar 2024

https://www.prnewswire.com/news-releases/tetra-pharm-technologies-advances-cb1-antagonist-tpt0701-for-appetite-suppression-into-preclinical-testing-302054792.html

PR NEWSWIRE
08 Feb 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty